ClinicalTrials.gg
RecruitingNCT07837180NeoMusicUpdated Sep 23, 2026

Effects of TUMATA and Mozart Music on Sleep and Comfort in NICU Newborns

An interventional study of TUMATA Music and Mozart Classical Music in Neonatal Intensive Care Unit (NICU), sponsored by Karamanoğlu Mehmetbey University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 0 Days to 28 Days, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-23.

Sponsored by Karamanoğlu Mehmetbey University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Mar 2025, registered Aug 2026).
  • Started Mar 2025; still recruiting 1 year 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
0 Days to 28 Days
Sex
All
01

Study summary

This study aims to evaluate the effects of two different types of music played in the neonatal intensive care unit on newborns' sleep and comfort levels. In this prospective, single-blind, crossover randomized controlled trial, newborns will receive TÜMATA music, Mozart classical music, and routine care (control) in different study periods. Sleep duration and comfort levels will be assessed using validated measurement tools to determine the effectiveness of music interventions in improving newborn comfort and sleep in the neonatal intensive care unit.

Read the detailed description

Sleep disturbances and discomfort are common among newborns admitted to neonatal intensive care units because of environmental stimuli and routine nursing procedures. Music interventions have been suggested as a safe, non-pharmacological approach to promote relaxation and improve neonatal well-being. However, evidence regarding the comparative effects of different types of music on newborn sleep and comfort remains limited.

The aim of this study is to compare the effects of Turkish Music (TÜMATA), Mozart classical music, and routine care on sleep and comfort levels in newborns hospitalized in a neonatal intensive care unit. This study is designed as a prospective, single-blind, crossover randomized controlled trial. Eligible newborns will receive each intervention according to the randomized crossover sequence. Sleep duration and comfort levels will be assessed using validated measurement tools at predetermined time points. The findings of this study are expected to provide evidence regarding the effectiveness of music interventions in supporting sleep and comfort among newborns in neonatal intensive care units.

02

Conditions studied

  • Neonatal Intensive Care Unit (NICU)

Keywords

  • Newborn
  • Music therapy
  • Sleep
  • Comfort
  • Randomized controlled trial
  • Nursing care
03

In context

Lead sponsor

Karamanoğlu Mehmetbey University is the lead sponsor of 69 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Days to 28 Days
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The infant must be in the neonatal period (aged 0-28 days).
  • The infant must have been admitted to the Neonatal Intensive Care Unit.
  • The infant must have been born at term (38 weeks or more).
  • The infant must be breathing spontaneously.
  • The infant must have finished feeding at least 30 minutes prior to the procedure.
  • The infant must not have received any analgesics and/or sedatives within the last 8 hours.
  • The parents must have consented to participate in the study.
  • The infant must have been admitted for at least 24 hours.

Exclusion criteria

Exclusion Criteria:

  • Newborns readmitted during the data collection period.
  • Newborns with respiratory problems.
  • Newborns whose parents declined to participate in the study.

Criteria for Withdrawal from the Study:

  • A change in the newborn's vital signs.
  • The parent's request to withdraw the newborn from the study.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
48 participants (estimated)

Study arms

  • Experimental
    TÜMATA Music

    Within the scope of this study, pentatonic music, as recommended by TÜMATA, will be applied.Music for newborns will be played in the room using a music player, in accordance with the recommendations of the American Academy of Pediatrics, at a level not exceeding 75 decibels. The sound will be 45 decibels at a distance of 30 cm from the newborn's ear, and the music's decibel level will be adjusted using a decibel meter. The decibel meter used to adjust the music decibel level will be calibrated.The music intervention is planned to be played for 45 minutes in recurring periods. Music sessions will be started and ended at the same times each day.The comfort levels and sleep of the newborns will be assessed and recorded before the procedure. The pre-procedure comfort assessment will be done immediately before the music is played, will be done after 10 minutes of music, and the post-procedure comfort assessment will be done when the newborn wakes up.

    Other: TUMATA Music

  • Experimental
    Mozart Classical Music

    Within the scope of this study, Mozart Classical Music will be applied.Music for newborns will be played in the room using a music player, in accordance with the recommendations of the American Academy of Pediatrics, at a level not exceeding 75 decibels. The sound will be 45 decibels at a distance of 30 cm from the newborn's ear, and the music's decibel level will be adjusted using a decibel meter. The decibel meter used to adjust the music decibel level will be calibrated.The music intervention is planned to be played for 45 minutes in recurring periods. Music sessions will be started and ended at the same times each day.The comfort levels and sleep of the newborns will be assessed and recorded before the procedure. The pre-procedure comfort assessment will be done immediately before the music is played, will be done after 10 minutes of music, and the post-procedure comfort assessment will be done when the newborn wakes up.

    Other: Mozart Classical Music

  • No intervention
    Routine Care

    Participants receive routine neonatal intensive care without music intervention. Standard nursing care is provided according to unit protocols. Sleep and comfort are assessed at the same time points as in the music intervention periods.

Interventions

  • OtherTUMATA Music

    Pentatonic music recommended by TÜMATA will be played to newborns through a music player during the intervention period.

  • OtherMozart Classical Music

    Mozart classical music will be played to newborns through a music player during the intervention period.

06

What researchers measure

Primary outcomes

  1. Sleep latency

    Sleep latency is defined as the time elapsed from the start of the music intervention (minute 0) until the newborn falls asleep. The time will be observed and recorded in minutes by the researcher.

    Time frame: From the start of the 45-minute music intervention (minute 0) until sleep onset

  2. Total sleep duration

    The time elapsed from sleep onset until spontaneous awakening will be observed and recorded in minutes by the researcher.

    Time frame: From sleep onset until spontaneous awakening

  3. Neonatal comfort level

    Newborn Comfort Behavior Scale The Scale (NICS) is a Likert-type scale consisting of six parameters: wakefulness, calmness/agitation, respiratory response, crying, body movements, facial tension, and muscle tone. In addition to determining comfort, the Neonatal Comfort Behavior Scale (NICS) is an assessment tool that includes quantitative rating scales to enable nurses to evaluate the baby's pain and distress. Each item on the scale is scored from 1 to 5. The total score is evaluated. The lowest possible score on the Neonatal Comfort Behavior Scale (NICS) is 6, and the highest is 30. If the total score is between 14 and 30, it indicates that the baby is in pain or distress, is uncomfortable, and requires interventions to provide comfort. Nurses or observers assess infants' pain and distress based on observations using numerical rating scales ranging from 0 to 10. Scores of 4-6 indicate moderate pain and distress, while scores of 7-10 indicate severe pain and distress.

    Time frame: Immediately before the intervention, at the 10th minute of the intervention, and immediately after the newborn awakens.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Mar 2025 (actual). Primary completion is estimated for Dec 2026, 21 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 6, 2026
First posted
Sep 23, 2026
StartActual
Mar 15, 2025
Primary completionEst.
Dec 31, 2026
CompletionEst.
Mar 15, 2027
Last update
Sep 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07837180
Lead sponsor
Karamanoğlu Mehmetbey University
Responsible party
Dr. Hatice Dönmez (Associate Professor, Karamanoğlu Mehmetbey University) — Principal investigator
First posted
Sep 23, 2026
Start date
Mar 15, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Mar 15, 2027 (estimated)
Last update
Sep 23, 2026

Study contacts

Hatice Dönmez, PhD
Contact
hdonmez@kmu.edu.tr
+90 0 506 771 58 41
hatice dönmez
principal investigator · Karamanoğlu Mehmetbey University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion